News

“Now that many more advertisers see the power of CTV, expect the growth trend to continue post-pandemic as the value proposition remains strong in driving a solid return on ad spend,” writes CMO Jon Schulz.

Jon Schulz, CMO at Viant, discusses the key considerations for marketers as industries get a handle on the immediate crisis of COVID-19 and start looking to chart their next steps.

“Programmatic linear marries the same brand-safe media execution marketers expect of linear TV with the transparent reporting intrinsic to digital,” writes VP Adam Paz.

As advertising continues to evolve and fragment, marketers need to develop new methods for engaging customers and connecting with their target audiences. By refocusing on individual households, industry leaders will be able to more effectively track performance and meet business goals, explains CMO Jon Schulz.

If pharma marketers are able to appropriately integrate new strategies, both their business and those who need their products will benefit. VP of Product Marketing Andrea Bras reveals a few things pharma marketers should consider as they incorporate digital advertising into their strategies.

With more consumer data available than ever before, it’s time to focus on data efficacy, transparency and consumer controls, writes VP of Programmatic Strategy Alex Perrin.

SVP Brian Bell shares the key factors that are influencing the shift from cookie to individual households and what advertisers can expect as they (re)enter a new era of digital marketing.

Now is the time to evaluate new demand-side platforms (DSPs) that can improve your workflows and campaign performance. CMO Jon Schulz reveals why.

Adelphic, the self-service programmatic ad platform, has partnered with Integral Ad Science to launch pre-bid custom keyword customization for advertisers.